Track Your Future Recoveries Withsnaptrade iconConnect Account

CTI BioPharma Corp. Settlement
(NASDAQ: CTIC)
Settlement

Claim Deadline: February 20, 2018

Settlement Fund: $20,000,000

Settlement Class

All persons or entities that purchased or otherwise acquired any shares of the common stock of CTI BioPharma Corp. (“CTI”), CTI Series N-1  Preferred Stock, or CTI Series N-2 Preferred Stock, other than shares of such securities that traded on an exchange outside  the United States (collectively, the “CTI Securities”), and were damaged thereby during the period from March 9, 2015 through February 9, 2016, inclusive.

Important Documents

Settlement Status

Disbursed

Class Period

March 09, 2015 - February 09, 2016

Settlement Hearing Date

February 01, 2018

Opt-Out Deadline

January 11, 2018

Settlement Website

N/A

Claims Admin

Garden City Group, LLC
 In re CTI BioPharma Corp. Securities Litigation    c/o GCGP.O. Box 35100Seattle, WA 98124-1100

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.